ATE408614T1 - Neue macrolide mit antibakterieller wirkung - Google Patents

Neue macrolide mit antibakterieller wirkung

Info

Publication number
ATE408614T1
ATE408614T1 AT01960680T AT01960680T ATE408614T1 AT E408614 T1 ATE408614 T1 AT E408614T1 AT 01960680 T AT01960680 T AT 01960680T AT 01960680 T AT01960680 T AT 01960680T AT E408614 T1 ATE408614 T1 AT E408614T1
Authority
AT
Austria
Prior art keywords
antibacterial effect
new macrolides
heterocyclyl
hydrogen
formula
Prior art date
Application number
AT01960680T
Other languages
German (de)
English (en)
Inventor
Peter Angehrn
Daniel Hunziker
Pierre-Charles Wyss
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of ATE408614T1 publication Critical patent/ATE408614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01960680T 2000-08-22 2001-08-20 Neue macrolide mit antibakterieller wirkung ATE408614T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22

Publications (1)

Publication Number Publication Date
ATE408614T1 true ATE408614T1 (de) 2008-10-15

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960680T ATE408614T1 (de) 2000-08-22 2001-08-20 Neue macrolide mit antibakterieller wirkung

Country Status (14)

Country Link
US (1) US6740642B2 (cg-RX-API-DMAC7.html)
EP (1) EP1313751B1 (cg-RX-API-DMAC7.html)
JP (1) JP4162992B2 (cg-RX-API-DMAC7.html)
KR (1) KR100502031B1 (cg-RX-API-DMAC7.html)
CN (1) CN1234718C (cg-RX-API-DMAC7.html)
AT (1) ATE408614T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001282105A1 (cg-RX-API-DMAC7.html)
BR (1) BR0113472A (cg-RX-API-DMAC7.html)
CA (1) CA2419296C (cg-RX-API-DMAC7.html)
DE (1) DE60135859D1 (cg-RX-API-DMAC7.html)
ES (1) ES2313975T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA03001607A (cg-RX-API-DMAC7.html)
WO (1) WO2002016380A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200301047B (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1492874A (zh) * 2000-12-21 2004-04-28 大环内酯
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
HRP20090302T1 (hr) 2005-02-09 2009-07-31 Basilea Pharmaceutica Ag Novi makrolidi
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
EP1934238B1 (en) 2005-08-24 2017-06-28 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
WO2008017696A1 (en) 2006-08-09 2008-02-14 Basilea Pharmaceutica Ag New macrolides useful against inflammatory and allergic disseases
CN101541331A (zh) * 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
KR101617897B1 (ko) * 2008-02-08 2016-05-03 바실리어 파마슈티카 아게 신규 마크로라이드 및 그의 용도
US8445451B2 (en) * 2008-02-08 2013-05-21 Basilea Pharmaceutica Ag Macrolides and uses of macrolides
EP2435460B1 (en) * 2009-05-27 2015-01-07 Wockhardt Limited Ketolide compounds having antimicrobial activity
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
CN103384676B (zh) 2010-12-09 2016-02-03 沃克哈特有限公司 酮内酯化合物
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
PT2938623T (pt) * 2012-12-31 2016-11-23 Basilea Pharmaceutica Ag Macrólidos selecionados com atividade inibitória de pde4
US10857171B2 (en) 2016-01-12 2020-12-08 Wockhardt Limited Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
CN1234718C (zh) 2006-01-04
JP2004506740A (ja) 2004-03-04
KR20030029839A (ko) 2003-04-16
US20030199459A1 (en) 2003-10-23
KR100502031B1 (ko) 2005-07-25
DE60135859D1 (de) 2008-10-30
EP1313751B1 (en) 2008-09-17
JP4162992B2 (ja) 2008-10-08
WO2002016380A1 (en) 2002-02-28
US6740642B2 (en) 2004-05-25
EP1313751A1 (en) 2003-05-28
CN1464880A (zh) 2003-12-31
CA2419296A1 (en) 2002-02-28
MXPA03001607A (es) 2003-06-04
CA2419296C (en) 2008-12-09
BR0113472A (pt) 2003-07-01
ES2313975T3 (es) 2009-03-16
AU2001282105A1 (en) 2002-03-04
ZA200301047B (en) 2004-05-06

Similar Documents

Publication Publication Date Title
DE60135859D1 (de) Neue macrolide mit antibakterieller wirkung
FR2742757B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FI923691A0 (fi) Cykliska iminoderivat, dessa foereningar innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning.
NO991700L (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
FI915136A0 (fi) Cykliska iminoderivat, dessa foereningar innehaollande laekemede och foerfarande foer deras framstaellning.
EP1256588A4 (en) NEW PYRAZINE DERIVATIVES OR SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR THEIR SALTS AND INTERMEDIATES FOR BOTH PRODUCTION
YU50002A (sh) Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju
CA2476884A1 (en) Macrolides with antibacterial activity
DK0992509T3 (da) Nye makrolid-derivater
DE69400817D1 (de) 9a-N-(N'-Carbamoyl)-und 9a-N-(N'Thiocarbamoyl)-Derivate von 9-Deoxo-9a-aza-9a-homoerythromycin A
ES2089863T3 (es) 9a,11-carbamatos ciclicos de 9-desoxo-9a-aza-11-desoxi-9a-homoeritromicina a.
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2760017B1 (fr) Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
DE60003671D1 (de) Halo-derivate von 9-deoxo-9a-aza-9a-homerythromycin a
ES2100177T3 (es) Compuestos de cefalosporina y su produccion.
ATE234320T1 (de) Beta,beta-disubstituierte derivate von 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
PT1575969E (pt) Derivados com substituicao 9a-n- (n'-4- ( sulfonil )fenil ) carbamoilo ) de 9-desoxo-9-dihidro-9a-aza-9a-homoeritromicina a e 5-0-desosaminil-9-desoxo-9-di-hidro-9a-aza-9a-homoeritronilida a
MXPA05006220A (es) Nuevos antibioticos macrolidos semisinteticos de la serie de azalidas.
EP0254582A3 (en) 6 beta-(alpha-oximino)-acylamino penicillanic-acid derivatives and starting compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee